Heart Attack :: Heart attack patient benefits from innovative technology
UCSD Medical Center cardiology and neurology specialists are using a novel method to save the lives of patients in cardiac arrest.
UCSD Medical Center cardiology and neurology specialists are using a novel method to save the lives of patients in cardiac arrest.
Innovative pulmonary and PEGylation-based therapeutic product development is the focus of two new business units recently created at Nektar Therapeutics (Nasdaq: NKTR), the company announced today.
The Friends of the Alzheimer?s Disease Center will hold its Spring Public Forum on April 24 at UT Southwestern Medical Center.
A new drug called Eslicarbazepine (ESL) shows promise as a treatment for epilepsy patients whose symptoms remain uncontrolled with existing medications.
Neuroscientists at UCLA have shown that lithium, long the standard treatment for bipolar disorder, increases the amount of gray matter in the brains of patients with the illness.
A mind-altering mutation in mice results in an enhanced long-term memory, researchers report in the April 6, 2007 issue of the journal Cell, published by Cell Press.
Flexible electronic membranes may overcome a longstanding dilemma faced by brain researchers: How to replicate injuries in the lab without destroying the electrodes that monitor how brain cells respond to physical trauma.
University of Cincinnati neuroradiologists believe a brain imaging approach that combines standard magnetic resonance imaging scans with specialized contrast-enhanced techniques could lead to more effective diagnoses in patients with difficult-to-detect blood clots in veins of the brain.
Immunology researchers at the Kimmel Cancer Center at Jefferson studying a multiple sclerosis (MS)-like disease in mice have shown that the amount of “damage” to the central nervous system?s protective blood-brain barrier ? in essence, opening it ? almost always correlates to the severity of the disease.
A mind-altering mutation in mice results in an enhanced long-term memory, researchers report in the April 6, 2007, issue of the journal Cell, published by Cell Press. These findings point to a potential target for the development of a drug to treat memory loss, according to the researchers.